ANTX
NASDAQ · Pharmaceuticals
An2 Therapeutics Inc
$4.68
+0.13 (+2.86%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+296.4% upside
Low Target
$11.23
Average Target
$18.55
High Target
$22.80
Current Price
$4.68
Current
$4.68
$4.68
Target
$18.55
$18.55
$11.23
$18.55 avg
$22.80
Scenario Analysis
Bear Case
$11.23
140.0%
Low target
Base Case
$18.55
+296.4%
Avg target
Bull Case
$22.80
+387.2%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$6.91
-32.3% from high
52-Week Low
$1.00
+368.0% from low
Target vs 52W High
$18.55
+168.5% vs high
Next Earnings Report
May 13, 2026
2d
until earnings
EPS Est: $-0.23
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals